BioLineRx (BLRX) Current Leases (2021 - 2025)

BioLineRx has reported Current Leases over the past 5 years, most recently at $234000.0 for Q4 2025.

  • Quarterly results put Current Leases at $234000.0 for Q4 2025, down 55.17% from a year ago — trailing twelve months through Dec 2025 was $234000.0 (down 55.17% YoY), and the annual figure for FY2025 was $234000.0, down 55.17%.
  • Current Leases for Q4 2025 was $234000.0 at BioLineRx, down from $522000.0 in the prior quarter.
  • Over the last five years, Current Leases for BLRX hit a ceiling of $528000.0 in Q4 2023 and a floor of $168000.0 in Q4 2021.
  • Median Current Leases over the past 5 years was $427000.0 (2022), compared with a mean of $375800.0.
  • Biggest five-year swings in Current Leases: surged 154.17% in 2022 and later crashed 55.17% in 2025.
  • BioLineRx's Current Leases stood at $168000.0 in 2021, then skyrocketed by 154.17% to $427000.0 in 2022, then rose by 23.65% to $528000.0 in 2023, then decreased by 1.14% to $522000.0 in 2024, then crashed by 55.17% to $234000.0 in 2025.
  • The last three reported values for Current Leases were $234000.0 (Q4 2025), $522000.0 (Q4 2024), and $528000.0 (Q4 2023) per Business Quant data.